ArticlePloS one2026
Correction: Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer.
PLOS One EditorsPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.